Sara Menendez-Laine
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Time-resolved mitochondrial screen identifies regulatory components of oxidative metabolism.
Journal: EMBO reports
Published: December 04, 2024
Pathophysiology of Cerebellar Degeneration in Mitochondrial Disorders: Insights from the Harlequin Mouse.
Journal: International journal of molecular sciences
Published: May 21, 2023
Apoptosis-Inducing Factor Deficiency Induces Tissue-Specific Alterations in Autophagy: Insights from a Preclinical Model of Mitochondrial Disease and Exercise Training Effects.
Journal: Antioxidants (Basel, Switzerland)
Published: February 11, 2022
Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
Journal: International journal of molecular sciences
Published: May 25, 2021
Preferent Diaphragmatic Involvement in TK2 Deficiency: An Autopsy Case Study.
Journal: International journal of molecular sciences
Published: April 06, 2021
Exercise Training and Neurodegeneration in Mitochondrial Disorders: Insights From the Harlequin Mouse.
Journal: Frontiers in physiology
Published: August 12, 2020
Physical Exercise and Mitochondrial Disease: Insights From a Mouse Model.
Journal: Frontiers in neurology
Published: March 28, 2019
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition.
Journal: Free radical biology & medicine
Published: September 11, 2018
Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling.
Journal: Free radical biology & medicine
Published: August 21, 2018
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.
Journal: Scientific reports
Published: August 11, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026